{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:42:04Z","timestamp":1788478924785,"version":"build-2803163510"},"reference-count":20,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This article addresses the diagnostic challenges encountered and resolution of a neonate with blocked D phenomenon, where maternal anti-D had masked the D sites on the neonate\u2019s red blood cells (RBCs), initially resulting in false-negative D typing. This article emphasizes the importance of integrating serologic and molecular methods for accurate blood type determination, which is crucial for managing hemolytic disease of the fetus and newborn. A mother, whose RBCs typed as D\u2013 and with a history of D isoimmunization, gave birth to a neonate who presented with anemia and jaundice. Initial D typing revealed the neonate had D\u2013 RBCs. The mother\u2019s blood sample tested as group B, D\u2013 with a high anti-D titer (512). The neonate\u2019s direct antiglobulin test (DAT) was strongly positive for IgG, and eluate testing confirmed anti-D specificity, indicating that maternal anti-D was coating the neonate\u2019s RBCs. Treatment of the neonate\u2019s RBCs with a commercial ZZAP reagent removed bound IgG antibodies, converting the DAT to negative and revealing the neonate\u2019s RBCs to be group B, D+, thereby resolving the initial serologic dilemma. Further polymerase chain reaction\u2013based molecular testing of the neonate\u2019s RBCs confirmed the D+ phenotype (R\n                    <jats:sub>1<\/jats:sub>\n                    R\n                    <jats:sub>1<\/jats:sub>\n                    ), demonstrating the utility of molecular methods in complex cases.\n                  <\/jats:p>","DOI":"10.2478\/immunohematology-2026-002","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T22:33:11Z","timestamp":1775946791000},"page":"1-5","source":"Crossref","is-referenced-by-count":1,"title":["Investigation of a neonate with blocked D phenomenon: resolving D type using serologic and molecular methods"],"prefix":"10.2478","volume":"42","author":[{"given":"Gunjan","family":"Bhardwaj","sequence":"first","affiliation":[{"name":"Department of Transfusion Medicine , Medanta , Haryana , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseem K.","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine , Medanta , Haryana , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Jacob","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine , Medanta , Haryana , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine , Medanta , Haryana , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowri","family":"Suresh","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine , Medanta , Haryana , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishika","family":"Konsal","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine , Medanta , Haryana , India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"2026041122330672955_j_immunohematology-2026-002_ref_001","doi-asserted-by":"crossref","unstructured":"Klein HG, Anstee DJ. The Rh blood group system (including LW and RHAG). In: Mollison\u2019s blood transfusion in clinical medicine. 12th ed. Hoboken, NJ: Wiley Blackwell, 2014: 167\u2013213.","DOI":"10.1002\/9781118689943.ch5"},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_002","unstructured":"Bajpayee A, Dubey A, Sonker A, Chaudhary RK. A case of severe foetal anaemia due to anti-M isoimmunisation salvaged by intrauterine transfusions. Blood Transfus 2014;12 (Suppl 1):s302."},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_003","doi-asserted-by":"crossref","unstructured":"Routray SS, Mishra D, Kanungo GN, Behera R. Hemolytic disease of newborn due to ABO incompatibility between B blood group mother and A blood group neonate. J Lab Physicians 2023;15:146\u20138.","DOI":"10.1055\/s-0042-1750071"},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_004","doi-asserted-by":"crossref","unstructured":"Hamel C, Esmaeilisaraji L, Thuku M, Michaud A, Sikora L, Fung-Kee-Fung K. Antenatal and postpartum prevention of Rh alloimmunization: a systematic review and GR ADE analysis. PLoS One 2020;15:e0238844.","DOI":"10.1371\/journal.pone.0238844"},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_005","doi-asserted-by":"crossref","unstructured":"Shah P, Chandraiah S, Rai S, Naik SN, Parvekar S, Thakur M. Prophylactic treatment and sensitization rates among pregnant Rh-negative women in India: a second interim analysis of a real-world, prospective, observational study (Rhythm). J South Asian Federation Obstet Gynaecol 2025;17(Suppl 1):S59\u2013S65.","DOI":"10.5005\/jp-journals-10006-2650"},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_006","doi-asserted-by":"crossref","unstructured":"Dziegiel MH, Krog GR, Hansen AT, et al. Laboratory monitoring of mother, fetus, and newborn in hemolytic disease of fetus and newborn. Transfus Med Hemother 2021;48:306\u201315.","DOI":"10.1159\/000518782"},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_007","doi-asserted-by":"crossref","unstructured":"Wiener AS. A new test (blocking test) for Rh sensitization. Proc Soc Exp Biol Med 1944;56:173\u20136.","DOI":"10.3181\/00379727-56-14640"},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_008","unstructured":"Method 4-1. Cold-acid elution procedure. In: Cohn CS, Delaney M, Johnson ST, Katz LM, Eds. AABB technical manual: methods and appendices. 20th ed. Available from https:\/\/www.aabb.org\/docs\/default-source\/default-document-library\/publications\/technical-manual-20th-edition-methods-and-appendices.docx?sfvrsn=8c9876fe_2. Accessed 1 August 2025."},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_009","doi-asserted-by":"crossref","unstructured":"Mangwana S, Bedi N, Simon N. Red cell autoantibodies: selection of blood for transfusion. Global J Transfus Med 2017;2:159\u201362.","DOI":"10.4103\/GJTM.GJTM_23_17"},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_010","unstructured":"Method 4\u20138. Adsorbing warm-reactive autoantibodies using autologous red cells. In: Cohn CS, Delaney M, Johnson ST, Katz LM, Eds. AABB technical manual: methods and appendices. 20th ed. Available from https:\/\/www.aabb.org\/docs\/default-source\/default-document-library\/publications\/technical-manual-20th-edition-methods-and-appendices.docx?sfvrsn=8c9876fe_2. Accessed 1 August 2025."},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_011","doi-asserted-by":"crossref","unstructured":"Judd WJ, Steiner EA, O\u2019Donnell DB, Oberman HA. Discrepancies in reverse ABO typing due to prozone: how safe is the immediate-spin crossmatch? Transfusion 1988;28: 334\u20138.","DOI":"10.1046\/j.1537-2995.1988.28488265261.x"},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_012","doi-asserted-by":"crossref","unstructured":"Ali A, Basany L, Priyanka GN, Lotkal RR. Blocked D phenomenon implicated in a diagnostic dilemma in RhD-hemolytic disease affecting twins: case report and review of literature. Turk J Pediatr 2025;67:259\u201367.","DOI":"10.24953\/turkjpediatr.2025.5786"},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_013","doi-asserted-by":"crossref","unstructured":"Mukherjee S, Das SS, Chowdhury S. \u201cBlock D\u201d phenomenon in hemolytic disease of fetus and newborn: the immunohematological implications. Global J Transfus Med. 2024;9: 95\u2013102.","DOI":"10.4103\/gjtm.gjtm_28_24"},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_014","doi-asserted-by":"crossref","unstructured":"Koelewijn JM, de Haas M, Vrijkotte TG, Van Der Schoot CE, Bonsel GJ. Risk factors for RhD immunisation despite ante-natal and postnatal anti-D prophylaxis. BJOG 2009;116: 1307\u201314.","DOI":"10.1111\/j.1471-0528.2009.02244.x"},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_015","doi-asserted-by":"crossref","unstructured":"Kulkarni T, Sakhavalkar P, Ingale YP, Deshpande TA. Haemolytic disease of newborn in a baby delivered by mother with complete anti-D prophylaxis: an unusual case report. J Clin Diagn Res 2024;18:4\u20136.","DOI":"10.7860\/JCDR\/2024\/69375.19428"},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_016","doi-asserted-by":"crossref","unstructured":"Slootweg YM, Zwiers C, Koelewijn JM, et al. Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study. BJOG 2022;129:1721\u201330.","DOI":"10.1111\/1471-0528.17118"},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_017","unstructured":"Verma A, Sachan D, Bajpayee A, Elhence P, Dubey A, Pradhan M. RhD blocking phenomenon implicated in an immunohaematological diagnostic dilemma in a case of RhD-haemolytic disease of the foetus. Blood Transfus 2013;11:140."},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_018","doi-asserted-by":"crossref","unstructured":"Thakkar GH, Shah MC, Bhatnagar NM, Shah SD. Severe haemolytic disease of newborn with possibility of blocked D phenomenon: a case report. BJKines National J Basic Applied Sci 2021;16:70\u20132.","DOI":"10.56018\/bjkines20240612"},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_019","doi-asserted-by":"crossref","unstructured":"Clausen FB. Introductory preface of blood group genotyping. Ann Blood 2023;8.","DOI":"10.21037\/aob-2023-02"},{"key":"2026041122330672955_j_immunohematology-2026-002_ref_020","unstructured":"Harmening DM. Modern blood banking & transfusion practices. Philadelphia, PA: FA Davis, 2018:121\u20132."}],"container-title":["Immunohematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/immunohematology-2026-002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T22:33:13Z","timestamp":1775946793000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/immunohematology-2026-002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,4,10]]},"published-print":{"date-parts":[[2026,3,1]]}},"alternative-id":["10.2478\/immunohematology-2026-002"],"URL":"https:\/\/doi.org\/10.2478\/immunohematology-2026-002","relation":{},"ISSN":["1930-3955"],"issn-type":[{"value":"1930-3955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}